In addition to this development, Universal Health Services recently announced the declaration of its quarterly dividend. Shareholders who were recorded as investors on June 1st received a payment of $0.20 per share on Thursday, June 15th. When extrapolated on an annualized basis, this represents a dividend payout ratio (DPR) of around 8.50% and yields 0.52%. The ex-dividend date for this particular dividend was May 31st.
Furthermore, it was revealed that Universal Health Services’ CEO Marc D. Miller executed a significant transaction involving the sale of company stock in May. On Wednesday, May 10th alone, Miller sold 44,110 shares at an average price per share amounting to $142.65. The total value of this particular transaction stood at an impressive $6,292,291.50. After completing this sale, Miller’s personal holdings in the company amounted to 160,383 shares with an approximate valuation of $22,878,634.95.
This transaction was documented and subsequently disclosed in filings submitted to the SEC as part of standard regulations regarding shareholder transparency and accountability within publicly traded companies.
Additionally worthy of note is another instance wherein CEO Marc D. Miller sold another batch of Universal Health Services’ shares on Wednesday, May 10th – again totaling precisely 44,110 shares. This second sale was valued at the same average price per share of $142.65, yielding an identical total value of $6,292,291.50. As a result, Miller’s remaining holdings in the company reflected ownership of 160,383 shares with an approximate value of $22,878,634.95.
On another front, Director Warren J. Nimetz also engaged in stock trades on June 13th by selling 800 shares at an average price per share of $140.97. The total value for this transaction amounted to $112,776.00. Following the sale, Nimetz’s direct holdings in Universal Health Services comprised 2,944 shares valued at approximately $415,015.68.
The sheer volume and frequency of insider transactions within Universal Health Services are quite striking. Over the past 90 days alone, insiders have collectively sold off 74,697 shares of company stock amounting to a total valuation of $10,547,996. While these sales signify a considerable divestment strategy on behalf of insiders within the organization itself and may be cause for investor introspection or uncertainty – it is essential to bear in mind that insiders still retain approximately 16.60% ownership stake in Universal Health Services’ stock.
As always with financial transactions and disclosures made by publicly traded companies such as Universal Health Services Inc., it is crucial for investors and market participants alike to keep themselves informed about these significant occurrences by accessing official filings available through recognized channels like SEC’s website.
In conclusion, Allspring Global Investments Holdings LLC has substantially reduced its holdings in Universal Health Services’, while CEO Marc D. Miller has made notable transactions involving large quantities of company stock over recent months for undisclosed reasons- making it an intriguing period to monitor developments around this major health services provider and understand its implications on market sentiment moving forward.
Recent Changes in Positions, Ratings, and Dividends of Universal Health Services, Inc. (UHS)
Universal Health Services, Inc. (UHS) has recently seen changes in the positions of various hedge funds. Raymond James Financial Services Advisors Inc. increased its stake in UHS by 9.0% during the first quarter, now owning 10,079 shares valued at $1,461,000. HighTower Advisors LLC also grew its stake in UHS by 1.6%, now owning 11,674 shares valued at $1,691,000. MetLife Investment Management LLC increased its stake by 22.9%, owning 19,853 shares valued at $2,878,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS saw a growth of 6.6% in their stake and now owns 9,784 shares valued at $1,418,000. Finally, BlackRock Inc.’s stake in UHS grew by 2.3%, with ownership of 5,026,512 shares valued at $728,594,000.
Recently several equities analysts have weighed in on UHS stock as well. SVB Securities upgraded the stock from a “market perform” rating to an “outperform” rating and raised its target price from $147 to $170. VNET Group reaffirmed an “assumes” rating on the stock while Deutsche Bank Aktiengesellschaft raised its price target from $145 to $155.
UHS announced a quarterly dividend payment on Thursday, June 15th for investors of record on Thursday, June 1st. The dividend payout ratio (DPR) is currently at 8.50%. UHS opened at $152.68 on Wednesday and has a fifty-two week low of $82.50 and a fifty-two week high of $158.57.
According to Bloomberg’s data analysis on UHS stock ratings as of July 12th , there are two sell ratings given by investment analysts, eight hold ratings, and six buy ratings. The consensus price target for UHS is $146.50.
In its earnings results announced on Tuesday, April 25th, UHS reported earnings per share (EPS) of $2.34 for the quarter, surpassing analysts’ consensus estimates of $2.15 by $0.19. The company also had revenue of $3.47 billion during the quarter, slightly higher than the consensus estimate of $3.45 billion.
Universal Health Services is a health services provider with a current market capitalization of $10.71 billion and a P/E ratio of 16.22. It has a debt-to-equity ratio of 0.78 and a beta of 1.29.
With these recent developments in its positions, ratings, dividend payouts, and earnings results, Universal Health Services continues to be a significant player in the healthcare industry with potential for growth in the coming year. Investors will need to closely monitor future updates and announcements from UHS to make informed decisions about their holdings in the company.
The post Significant Reduction in Holdings and Insider Transactions at Universal Health Services appeared first on Best Stocks.
